LXRX - Lexicon Pharmaceuticals GAAP EPS of -$0.17 beats by $0.01 revenue of $0.02M misses by $0.01M
2023-05-02 16:32:38 ET
- Lexicon Pharmaceuticals press release ( NASDAQ: LXRX ): Q1 GAAP EPS of -$0.17 beats by $0.01 .
- Revenue of $0.02M (-50.0% Y/Y) misses by $0.01M .
For further details see:
Lexicon Pharmaceuticals GAAP EPS of -$0.17 beats by $0.01, revenue of $0.02M misses by $0.01M